Document is current
Any future updates will be listed below
-
Authors
Schmidt-Malan, Suzannah M.
Greenwood-Quaintance, Kerryl E.
Berglund, Lawrence J.
Mandrekar, Jayawant
Patel, Robin http://orcid.org/0000-0001-6344-4141
-
Funding
Funding for this research was provided by:
The Medicines Company
Mayo Clinic Materials and Structural Testing Research Core
- License Information
-
More Information
Article History
Received: 13 October 2017
Accepted: 28 January 2019
First Online: 12 February 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: SSM reports grants from The Medicines Company, during the conduct of the study. KGQ, LB, and JM have nothing to disclose. RP reports grants from CD Diagnostics, BioFire, Curetis, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. RP is a consultant to Curetis, Specific Technologies, Selux Dx, GenMark Diagnostics, PathoQuest, Heraeus Medical, and Qvella; monies are paid to Mayo Clinic. In addition, RP has a patent on <i>Bordetella pertussis</i>/<i>parapertussis</i> PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. RP served on an Actelion data monitoring board. RP receives travel reimbursement from Roche, ASM, and IDSA, an editor’s stipend from ASM and IDSA, and honoraria from the NBME, Up-to-Date, and the Infectious Diseases Board Review Course.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
